drugset / Trial / NCT02672241
Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of nimotuzumab in combination of radio-chemotherapy for the treatment of brainstem tumor in children.
Timeline
- Start
- 2016-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nimotuzumab | Monoclonal antibody | 150 mg/m2 | Intravenous |
| Background | Temozolomide | Small molecule | 200 mg/m2 | — |